Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue

Lung Cancer

Volumn 75, Issue 1, 2012, Pages 45-57

  Gottschling, Sandra ^a   Jauch, Anna ^b   Kuner, Ruprecht ^c   Herpel, Esther ^b   Mueller Decker, Karin ^c   Schnabel, Philipp A ^b   Xu, Elizabeth C ^a   Muley, Thomas ^a   Sültmann, Holger ^c   Bender, Christian ^c   Granzow, Martin ^b,d   Efferth, Thomas ^e   Hoffmann, Hans ^a   Dienemann, Hendrik ^a   Herth, Felix J F ^a   Meister, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Quantiom Bioinformatics GmbH and Co KG   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cell lines; Gene expression profile; Genotype; Non small cell lung cancer; Squamous cell carcinoma; Surface marker profile

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN;

ANGIOGENESIS; ARTICLE; CANCER TISSUE; CARCINOGENICITY; CELL ADHESION; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CHEMOSENSITIVITY; COMPARATIVE GENOMIC HYBRIDIZATION; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL;

ANIMALS; CARCINOGENICITY TESTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL LINEAGE; CELL MOVEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; DNA FINGERPRINTING; GENE EXPRESSION PROFILING; GENES, RAS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; TANDEM REPEAT SEQUENCES;

EID: 83555165211     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.020     Document Type: Article

References (40)

1. American Cancer Society: Cancer Statistics; 2008. http://www.cancer.org/docroot/STT/stt_0.asp.
2. Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002, 346:92-98. Eastern Cooperative Oncology Group.
3. Oie H.K., Russell E.K., Carney D.N., Gazdar A.F. Cell culture methods for the establishment of the NCI series of lung cancer cell lines. J Cell Biochem 1996, Suppl. 24:24-31.
4. Brower M., Carney D.N., Oie H.K., Gazdar A.F., Minna J.D. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 1986, 46:798-806.
5. Masuda N., Fukuoka M., Takada M., Kudoh S., Kusunoki Y. Establishment and characterization of 20 human non-small cell lung cancer cell lines in a serum-free defined medium (ACL-4). Chest 1991, 100:429-438.
6. Sugaya M., Takenoyama M., Osaki T., Yasuda M., Nagshima A., Sugio K., et al. Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy. Chest 2002, 122:282-288.
7. Wistuba I.I., Bryant D., Behrens C., Milchgrub S., Virmani A.K., Ashfaq R., et al. Comparison of features of human lung cancer cell lines and their corresponding tumors. Clin Cancer Res 1999, 5:991-1000.
8. Wistuba I.I., Behrens C., Milchgrub S., Salahuddin S., Ahmadian M., Virmani A.K., et al. Comparison of features of human breast cancer cell lines and their corresponding tumor tissue. Clin Cancer Res 1998, 4:2931-2938.
9. Virtanen C., Ishikawa Y., Honjoh D., Kimura M., Shimane M., Miyoshi T., et al. Integrated classification of lung tumors and cell lines by expression profiling. Proc Natl Acad Sci USA 2002, 99:12357-12362.
10. Vegiopoulos A., Müller-Decker K., Strzoda D., Schmitt I., Chichelnitskiy E., Ostertag A., et al. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 2010, 328:1158-1161.
11. Reinmuth N., Jauch A., Chang Xu E., Muley T., Granzow M., Hoffmann H., et al. Correlation of EGFR mutations with chromosomal alterations and expression of EGFR. Lung Cancer 2008, 62:193-201.
12. Geigl J.B., Uhrig S., Speicher M.R. Multiplex-fluorescence in situ hybridization for chromosome karyotyping. Nat Protoc 2006, 1:1172-1184.
13. Masters J.R., Thomson J.A., Daly-Burns B., Reid Y.A., Dirks W.G., Packer P., et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 2001, 98:8012-8017.
14. Meister M., Schirmacher P., Dienemann H., Mechtersheimer G., Schnabel P.A., Kern M.A., et al. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Cancer Lett 2007, 248:186-191.
15. Kuner R., Muley T., Meister M., Ruschhaupt M., Buness A., Xu E.C., et al. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer 2009, 63:32-38.
16. Bepler G., Koehler A., Kiefer P., Havemann K., Beisenherz K., Jaques G., et al. Characterization of the state of differentiation of six newly established human non-small cell lung cancer cell lines. Differentiation 1988, 37:158-171.
17. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973, 51:1417-1423.
18. Downey P., Cummins R., Moran M., Gulmann G. If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of the lung. APMIS 2008, 116:526-529.
19. Kargi A., Gurel D., Tuna B. The diagnostic value of TTF-1, CK5/6, and p63 immunostaining in classification of lung carcinomas. Appl Immunohistochem Mol Morphol 2007, 15:415-420.
20. Kaufmann O., Fietze E., Mengs J., Dietel M. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001, 116:823-830.
21. Butnor K.J., Burchette J.L., Sporn T.A., Hammar S.P., Roggli V.L. The spectrum of kit (CD117) immunoreactivity in lung and pleural tumors. Arch Pathol Lab Med 2004, 128:538-543.
22. Pelosi G., Barisella M., Pasini F., Leon M.E., Veronesi G., Spaggiari L., et al. CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients. Mod Pathol 2004, 17:711-721.
23. Levina V., Marrangoni A., Wang T., Parikh S., Su Y., Herbeman R., et al. Elimination of human lung cancer stem cells through targeting of the stem cell factor c-kit autocrine signaling loop. Cancer Res 2010, 70:338-346.
24. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Diff 2008, 15:504-514.
25. Levina V., Marrangoni A.M., DeMarco R., Gorelik E., Lokshin A.E. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 2008, 3:e3077.
26. Chen Y.-C., Hsu H.-D., Chen Y.-W., Tsai T.-H., How C.-K., Wang C.-Y., et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133 positive cells. PLoS One 2008, 3:e2637.
27. INK4A and Cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol 1999, 188:351-360.
28. Tomizawa Y., Sekido Y., Kondo M., Gao B., Yokota J., Roche J., et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 2001, 98:13954-13959.
29. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000, 25:315-319.
30. Ohgaki H., Kros J.M., Okamoto Y., Gaspert A., Huang H., Kurrer M.O. APC mutations are infrequent but present in human lung cancer. Cancer Lett 2004, 207:197-203.
31. Petersen S., Aninat-Meyer M., Schlüns K., Gellert K., Dietl M., Petersen I. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 2000, 82:65-73.
32. Takahashi K., Kohno T., Matsumtot S., Nakanishi Y., Arai Y., Yamamoto S., et al. Clonal and parallel evolution of primary lung cancers and their metastases revealed by molecular dissection of cancer cells. Clin Cancer Res 2007, 13:111-120.
33. Bentz M., Plesch A., Stilgenbauer S., Doehner H., Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 1998, 21:172-175.
34. Speicher M.R., Petersen S., Uhrig S., Jentsch I., Fauth C., Eils R., et al. Analysis of chromosomal alterations in non-small cell lung cancer by Multiplex-FISH, comparative genomic hybridization, and multicolor bar coding. Lab Invest 2000, 80:1031-1041.
35. Gazdar A.F., Gao B., Minna J.D. lung cancer cell lines: useless artifacts or invaluable tools for medical science?. Lung Cancer 2010, 68:309-318.
36. Van Staveren W.C.G., Weiss Solís D.Y., Hébrant A., Detours V., Dumont J.E., Maenhaut C. human cancer cell lines: experimental models for cancer cells in situ? For cancer stem cells?. Biochim Biophys Acta 2009, 1795:92-103.
37. Gao C.F., Furge K., Koeman J., Dykema K., Su Y., Cutler M.L., et al. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc Natl Acad Sci USA 2007, 104:8995-9000.
38. Kim M.P., Gallick G.E. Gemcitabine resistance in pancreatic cancer: picking the key players. Clin Cancer Res 2008, 14:1284-1285.
39. Hanauske A.R., Eismann U., Oberschmidt O., Pospisil H., Hoffmann S., Hanauske-Abel H., et al. In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression. Invest New Drugs 2007, 25:417-423.
40. Cobo M., Isla D., Massuti B., Montes A., Sanchez J.M., Provencio M., et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small cell lung cancer. J Clin Oncol 2007, 25:2747-2754.